These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23268195)

  • 41. [Comparison of patients with schizophrenia, obsessive-compulsive disorder, and schizophrenia with accompanying obsessive-compulsive symptoms].
    Güleç G; Güneş E; Yenilmez C
    Turk Psikiyatri Derg; 2008; 19(3):247-56. PubMed ID: 18791877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Shining light on translational research in deep brain stimulation].
    Lüscher C; Davoine E; Bellone C
    Rev Med Suisse; 2015 Apr; 11(472):987-8, 990-1. PubMed ID: 26062226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Schizophrenic with obsessive-compulsive disorder or symptoms].
    Doubremelle C; Millet B; Olie JP
    Encephale; 2000; 26(2):81-8. PubMed ID: 10858921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deep brain stimulation for addiction: why the subthalamic nucleus should be favored.
    Pelloux Y; Baunez C
    Curr Opin Neurobiol; 2013 Aug; 23(4):713-20. PubMed ID: 23537902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Obsessive compulsive disorders].
    Encephale; 1993 Jul; 19 Spec No 2():425-35. PubMed ID: 8281909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ethical considerations in deep brain stimulation for psychiatric illness.
    Grant RA; Halpern CH; Baltuch GH; O'Reardon JP; Caplan A
    J Clin Neurosci; 2014 Jan; 21(1):1-5. PubMed ID: 24055023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Charting the road forward in psychiatric neurosurgery: proceedings of the 2016 American Society for Stereotactic and Functional Neurosurgery workshop on neuromodulation for psychiatric disorders.
    Bari AA; Mikell CB; Abosch A; Ben-Haim S; Buchanan RJ; Burton AW; Carcieri S; Cosgrove GR; D'Haese PF; Daskalakis ZJ; Eskandar EN; Gerrard JL; Goodman WK; Greenberg BD; Gross RE; Hamani C; Kiss ZHT; Konrad P; Kopell BH; Krinke L; Langevin JP; Lozano AM; Malone D; Mayberg HS; Miller JP; Patil PG; Peichel D; Petersen EA; Rezai AR; Richardson RM; Riva-Posse P; Sankar T; Schwalb JM; Simpson HB; Slavin K; Stypulkowski PH; Tosteson T; Warnke P; Willie JT; Zaghloul KA; Neimat JS; Pouratian N; Sheth SA
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):886-896. PubMed ID: 29371415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exercise and physical activity in mental disorders: clinical and experimental evidence.
    Zschucke E; Gaudlitz K; Ströhle A
    J Prev Med Public Health; 2013 Jan; 46 Suppl 1(Suppl 1):S12-21. PubMed ID: 23412549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene therapy for psychiatric disorders.
    Thome J; Hässler F; Zachariou V
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1(Suppl 1):16-8. PubMed ID: 21905989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
    Gessler DJ; Gao G
    Methods Mol Biol; 2016; 1382():429-65. PubMed ID: 26611604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunotherapy for brain diseases and mental illnesses.
    Singh VK
    Prog Drug Res; 1997; 48():129-46. PubMed ID: 9204685
    [No Abstract]   [Full Text] [Related]  

  • 52. Schizophrenia and other mental disorders require long-term adoptive immunotherapy.
    Wank R
    Med Hypotheses; 2002 Aug; 59(2):154-8. PubMed ID: 12208201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene therapy in psychiatric disorders: too early, too complex?
    Neumaier JF
    Curr Opin Pharmacol; 2003 Feb; 3(1):68-72. PubMed ID: 12550744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Focus on psychiatric disorders.
    Nat Neurosci; 2016 Oct; 19(11):1381-1382. PubMed ID: 27786178
    [No Abstract]   [Full Text] [Related]  

  • 55. Gene Therapy for Endocrine Disorders: A Promising Intervention.
    Darukhanavala A; Flotte TR
    Hum Gene Ther; 2022 Aug; 33(15-16):780-781. PubMed ID: 35972326
    [No Abstract]   [Full Text] [Related]  

  • 56. Adeno-associated virus-mediated cancer gene therapy: current status.
    Luo J; Luo Y; Sun J; Zhou Y; Zhang Y; Yang X
    Cancer Lett; 2015 Jan; 356(2 Pt B):347-56. PubMed ID: 25444906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Common Denominators of Parkinson's Disease Pathogenesis and Methamphetamine Abuse.
    Vincent B; Shukla M
    Curr Neuropharmacol; 2024; 22(13):2113-2156. PubMed ID: 37691228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interspecies Differences in the Connectivity of Ventral Striatal Components Between Humans and Macaques.
    Xia X; Fan L; Cheng C; Yao R; Deng H; Zhao D; Li H; Jiang T
    Front Neurosci; 2019; 13():623. PubMed ID: 31258468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective treatment of Parkinson's disease by a siRNA-LDH nanoconjugate.
    Acharya R; Chakraborty M; Chakraborty J
    Medchemcomm; 2019 Feb; 10(2):227-233. PubMed ID: 30881611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65.
    Hudry E; Andres-Mateos E; Lerner EP; Volak A; Cohen O; Hyman BT; Maguire CA; Vandenberghe LH
    Mol Ther Methods Clin Dev; 2018 Sep; 10():197-209. PubMed ID: 30109242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.